about
S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balanceDiagnosis trajectories of prior multi-morbidity predict sepsis mortality.Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.TEMPORAL ORDER OF DISEASE PAIRS AFFECTS SUBSEQUENT DISEASE TRAJECTORIES: THE CASE OF DIABETES AND SLEEP APNEA.A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.Comorbidity landscape of the Danish patient population affected by chromosome abnormalities
P50
Q35104378-2AEED1BD-A578-44F7-B0FF-376613D9BCCAQ37393943-9582ADA8-F5DD-4C12-B1A8-B808BD472A76Q38901400-919FE562-2D4C-43B4-8FE3-BE11F61766B5Q39212411-7A953DC2-EDBC-46E8-9688-6B6B481362B9Q40451877-CEA1F3DA-F4F6-486A-9C5C-A01987EDA73FQ42112839-8329E9BB-E564-4454-B437-CAB59B4D2737Q90284127-6B0779DE-7F49-4FE6-B984-3A40350A7845
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mette K Beck
@ast
Mette K Beck
@en
Mette K Beck
@es
Mette K Beck
@nl
type
label
Mette K Beck
@ast
Mette K Beck
@en
Mette K Beck
@es
Mette K Beck
@nl
prefLabel
Mette K Beck
@ast
Mette K Beck
@en
Mette K Beck
@es
Mette K Beck
@nl
P106
P31
P496
0000-0001-8302-083X